139 related articles for article (PubMed ID: 33073682)
1. Significance of "de novo" appearance of thyroglobulin antibodies in patients with differentiated thyroid cancer.
Scappaticcio L; Trimboli P; Verburg FA; Giovanella L
Int J Biol Markers; 2020 Sep; 35(3):41-49. PubMed ID: 33073682
[TBL] [Abstract][Full Text] [Related]
2. The
Yin N; Sherman SI; Pak Y; Litofsky DR; Gianoukakis AG;
Thyroid; 2020 Oct; 30(10):1490-1495. PubMed ID: 32228151
[No Abstract] [Full Text] [Related]
3. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
[TBL] [Abstract][Full Text] [Related]
4. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
Görges R; Maniecki M; Jentzen W; Sheu SN; Mann K; Bockisch A; Janssen OE
Eur J Endocrinol; 2005 Jul; 153(1):49-55. PubMed ID: 15994745
[TBL] [Abstract][Full Text] [Related]
5. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study.
Rubello D; Casara D; Girelli ME; Piccolo M; Busnardo B
J Nucl Med; 1992 Aug; 33(8):1478-80. PubMed ID: 1634938
[TBL] [Abstract][Full Text] [Related]
6. Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
Dekker BL; van der Horst-Schrivers ANA; Sluiter WJ; Brouwers AH; Lentjes EGWM; Heijboer AC; Muller Kobold AC; Links TP
Thyroid; 2019 Jan; 29(1):71-78. PubMed ID: 30351209
[TBL] [Abstract][Full Text] [Related]
7. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
Lee ZJO; Eslick GD; Edirimanne S
Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
[No Abstract] [Full Text] [Related]
8. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
Azmat U; Porter K; Senter L; Ringel MD; Nabhan F
Thyroid; 2017 Jan; 27(1):74-80. PubMed ID: 27736322
[TBL] [Abstract][Full Text] [Related]
10. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.
Spencer C; LoPresti J; Fatemi S
Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):394-404. PubMed ID: 25122493
[TBL] [Abstract][Full Text] [Related]
11. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
[TBL] [Abstract][Full Text] [Related]
13. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
Stanojevic M; Savin S; Cvejic D; Djukic A; Jeremic M; Zivancević Simonovic S
J Clin Lab Anal; 2009; 23(5):341-6. PubMed ID: 19774624
[TBL] [Abstract][Full Text] [Related]
15. Long-term predictive value of highly sensitive thyroglobulin measurement.
Bögershausen LR; Giovanella L; Stief T; Luster M; Verburg FA
Clin Endocrinol (Oxf); 2023 Apr; 98(4):622-628. PubMed ID: 36263618
[TBL] [Abstract][Full Text] [Related]
16. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
17. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery.
Okosieme OE; Evans C; Moss L; Parkes AB; Premawardhana LD; Lazarus JH
Clin Chem; 2005 Apr; 51(4):729-34. PubMed ID: 15695326
[TBL] [Abstract][Full Text] [Related]
18. Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
Dekker BL; van der Horst-Schrivers ANA; Brouwers AH; Shuford CM; Kema IP; Muller Kobold AC; Links TP
Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36169927
[TBL] [Abstract][Full Text] [Related]
19. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin antibodies in differentiated thyroid cancer.
Hjiyiannakis P; Mundy J; Harmer C
Clin Oncol (R Coll Radiol); 1999; 11(4):240-4. PubMed ID: 10473720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]